Guardian Bio
Biotechnology
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
Guardian Bio Overview
- Website
- www.guardian-bio.com
- Industry
- Biotechnology
- Employees
- 3
- Founded
- 2022
- Funding
- 500.0K
Keywords
About Guardian Bio
The Problem: Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells in particular are the generals of the immune system, directing and dictating immune responses. So it comes as no surprise that data has shown that dendritic cells are often dysfunctional in cancer patients. Guardian Bio's Solution: At Guardian Bio, our approach is focused on creating a personalized cell therapy based on dendritic cells. Our product drives anti-tumor activity through eliciting a diverse yet targeted immune response - mobilizing the entire army for the fight. We take stem cells from patients and turn them into cancer-targeted dendritic cells. Injecting our product back into patients will revitalize their immune system and give it the help it needs to win.
Guardian Bio Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
Guardian Bio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Max Krummel | Ucsf Professor, Founder and Partner |
View
|
|
| Richard Barrett, Phd. | Eir at Collage Venture Partners | Miami, Florida, United States |
Email
|
Compare Similar Companies to Guardian Bio
Nucleate
Biotechnology Research
Cellino
Biotechnology Research
Collage Venture Partners
Biotechnology Research
Kano Therapeutics
Biotechnology Research
Petri
Biotechnology
Surgicure Technologies, Inc.
Medical Equipment Manufacturing
Promakhos Therapeutics
Biotechnology Research
Torpedo Therapeutics
Nanotechnology Research
Davinci Wearables
Wellness And Fitness Services
UrSure, Inc.
Medical Equipment Manufacturing